AGP Executive Report
Last update: 3 hours agoHemp policy shake-up: A new U.S. federal “total THC” standard is set to tighten the rules on intoxicating hemp products, with a Dec. 11 delay for most provisions but synthetic and lab-converted cannabinoids still facing an earlier ban—raising the stakes for retailers and insurers. Legal cannabis enforcement: Northwest Indiana saw cannabis arrests drop from 2021 to 2025 despite nearby adult-use legalization, showing enforcement patterns can shift even when state laws change. Industry spotlight: Dunbar Pharma will present dronabinol API supply capabilities at expopharm 2026 in Munich, focusing on batch consistency and long-term availability for compounded medicines. Cross-border drug cases: Nigeria’s NNPC disowned a truck linked to a 2,145kg cannabis bust, while NDLEA reports continued large-scale interceptions. Court developments: Malaysia’s appeal in a cannabis trafficking acquittal case hit a service snag, with Interpol tracing the defendant for prosecution’s next steps. Public debate: A New Hampshire lawmaker said she’d back federal cannabis legalization, arguing law enforcement resources should target major threats like opioids and cartels.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
